These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 11967649

  • 21. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B, Romer M, Constantinescu R, Biglan K, Brocht A, Kieburtz K, Shoulson I, McDermott MP.
    Mov Disord; 2008 Jul 15; 23(9):1223-7. PubMed ID: 18512767
    [Abstract] [Full Text] [Related]

  • 22. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
    Gómez-Ansón B, Alegret M, Muñoz E, Monté GC, Alayrach E, Sánchez A, Boada M, Tolosa E.
    Parkinsonism Relat Disord; 2009 Mar 15; 15(3):213-9. PubMed ID: 18632301
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A study of arm movements in Huntington's disease under visually controlled and blindfolded conditions.
    Carella F, Bressanelli M, Piacentini S, Soliveri P, Geminiani G, Monza D, Albanese A, Girotti F.
    Neurol Sci; 2003 Feb 15; 23(6):287-93. PubMed ID: 12624715
    [Abstract] [Full Text] [Related]

  • 26. [Evolution of locomotion disorders in Huntington's disease].
    Delval A, Krystkowiak P, Blatt JL, Delliaux M, Destée A, Derambure P, Defebvre L.
    Neurophysiol Clin; 2008 Apr 15; 38(2):117-25. PubMed ID: 18423332
    [Abstract] [Full Text] [Related]

  • 27. Role of attentional resources on gait performance in Huntington's disease.
    Delval A, Krystkowiak P, Delliaux M, Dujardin K, Blatt JL, Destée A, Derambure P, Defebvre L.
    Mov Disord; 2008 Apr 15; 23(5):684-9. PubMed ID: 18175353
    [Abstract] [Full Text] [Related]

  • 28. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches.
    Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM.
    J Int Neuropsychol Soc; 2007 May 15; 13(3):539-43. PubMed ID: 17445303
    [Abstract] [Full Text] [Related]

  • 29. Grasping premanifest Huntington's disease - shaping new endpoints for new trials.
    Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW.
    Mov Disord; 2010 Dec 15; 25(16):2858-62. PubMed ID: 20818671
    [Abstract] [Full Text] [Related]

  • 30. [Speed of ocular saccades in Huntington disease. Prospective study].
    García Ruiz PJ, Cenjor C, Ulmer E, Hernández J, Cantarero S, Fanjul S, García de Yébenes J.
    Neurologia; 2001 Feb 15; 16(2):70-3. PubMed ID: 11257932
    [Abstract] [Full Text] [Related]

  • 31. Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness.
    Rao AK, Muratori L, Louis ED, Moskowitz CB, Marder KS.
    Gait Posture; 2009 Apr 15; 29(3):433-6. PubMed ID: 19111470
    [Abstract] [Full Text] [Related]

  • 32. Bradykinesia in early Huntington's disease.
    Sánchez-Pernaute R, Künig G, del Barrio Alba A, de Yébenes JG, Vontobel P, Leenders KL.
    Neurology; 2000 Jan 11; 54(1):119-25. PubMed ID: 10636136
    [Abstract] [Full Text] [Related]

  • 33. Poor dopaminergic response of impaired dexterity in Parkinson's disease: Bradykinesia or limb kinetic apraxia?
    Gebhardt A, Vanbellingen T, Baronti F, Kersten B, Bohlhalter S.
    Mov Disord; 2008 Sep 15; 23(12):1701-6. PubMed ID: 18649388
    [Abstract] [Full Text] [Related]

  • 34. Rate of change in early Huntington's disease: a clinicometric analysis.
    Meyer C, Landwehrmeyer B, Schwenke C, Doble A, Orth M, Ludolph AC, EHDI Study Group.
    Mov Disord; 2012 Jan 15; 27(1):118-24. PubMed ID: 22095693
    [Abstract] [Full Text] [Related]

  • 35. Correlates of early disability in Huntington's disease.
    Mayeux R, Stern Y, Herman A, Greenbaum L, Fahn S.
    Ann Neurol; 1986 Dec 15; 20(6):727-31. PubMed ID: 2949692
    [Abstract] [Full Text] [Related]

  • 36. Assessment of the nutrition status of patients with Huntington's disease.
    Trejo A, Tarrats RM, Alonso ME, Boll MC, Ochoa A, Velásquez L.
    Nutrition; 2004 Feb 15; 20(2):192-6. PubMed ID: 14962685
    [Abstract] [Full Text] [Related]

  • 37. Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters.
    Roth J, Klempìi J, Jech R, Zidovská J, Uhrová T, Doubek P, Ulmanová O, Brozová H, Volfová M, Serranová T, Ruzicka E.
    Funct Neurol; 2005 Feb 15; 20(3):127-30. PubMed ID: 16324236
    [Abstract] [Full Text] [Related]

  • 38. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J.
    J Neurol Sci; 2005 Dec 15; 239(1):11-9. PubMed ID: 16185716
    [Abstract] [Full Text] [Related]

  • 39. Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: differential effects on bradykinesia.
    Kishore A, Espay AJ, Marras C, Al-Khairalla T, Arenovich T, Asante A, Miyasaki J, Lang AE.
    Mov Disord; 2007 Feb 15; 22(3):328-33. PubMed ID: 17216641
    [Abstract] [Full Text] [Related]

  • 40. Predictors of neuropathological severity in 100 patients with Huntington's disease.
    Rosenblatt A, Abbott MH, Gourley LM, Troncoso JC, Margolis RL, Brandt J, Ross CA.
    Ann Neurol; 2003 Oct 15; 54(4):488-93. PubMed ID: 14520661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.